Literature DB >> 1538155

Gamma delta T lymphocytes in human tuberculosis.

P F Barnes1, C L Grisso, J S Abrams, H Band, T H Rea, R L Modlin.   

Abstract

The manifestations of tuberculous infection reflect the immune response to infection. Most healthy tuberculin reactors develop protective immunity; tuberculous pleuritis reflects a resistant response manifest by mild disease, whereas advanced pulmonary and miliary tuberculosis reflect ineffective immunity. The role of gamma delta T cells was assessed in tuberculous infection by evaluating expansion of these cells from blood mononuclear cells after stimulation with Mycobacterium tuberculosis. After culture in vitro, the percentages of gamma delta+ cells were significantly greater in patients with protective and resistant immunity (tuberculin reactors, 25% +/- 4%; tuberculous pleuritis, 30% +/- 7%) than in those with ineffective immunity (advanced pulmonary tuberculosis, 9% +/- 3%; miliary tuberculosis, 2% +/- 1%). In leprosy, expansion of gamma delta+ cells was greater in immunologically resistant tuberculoid patients (32% +/- 4%) than in Mycobacterium leprae-unresponsive lepromatous patients (9% +/- 2%). M. tuberculosis-reactive gamma delta T cell lines produced interferon-gamma, granulocyte-macrophage colony-stimulating factor, interleukin-3, and tumor necrosis factor-alpha, cytokines that activate macrophages and may contribute to mycobacterial elimination. These findings suggest that gamma delta T cells contribute to immune resistance against M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538155     DOI: 10.1093/infdis/165.3.506

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

Review 1.  Intraepithelial gamma delta T lymphocytes: sentinel cells at mucosal barriers.

Authors:  D A Ferrick; D P King; K A Jackson; R K Braun; S Tam; D M Hyde; B L Beaman
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Immune response to Encephalitozoon cuniculi infection.

Authors:  I A Khan; M Moretto; L M Weiss
Journal:  Microbes Infect       Date:  2001-04       Impact factor: 2.700

3.  Dynamic changes in circulating and antigen-responsive T-cell subpopulations post-Mycobacterium bovis infection in cattle.

Authors:  J M Pollock; D A Pollock; D G Campbell; R M Girvin; A D Crockard; S D Neill; D P Mackie
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

4.  Innate-like gammadelta T cell responses to mycobacterium Bacille Calmette-Guerin using the public V gamma 2 repertoire in Macaca fascicularis.

Authors:  Cristiana Cairo; Andrew M Hebbeler; Nadia Propp; Joseph L Bryant; Vittorio Colizzi; C David Pauza
Journal:  Tuberculosis (Edinb)       Date:  2007-02-09       Impact factor: 3.131

5.  Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.

Authors:  H Veenstra; R Baumann; N M Carroll; P T Lukey; M Kidd; N Beyers; C T Bolliger; P D van Helden; G Walzl
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 6.  Immunobiology of Mycobacterium avium infection.

Authors:  L E Bermudez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 7.  gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?

Authors:  S H Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

8.  Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients.

Authors:  C Ueta; I Tsuyuguchi; H Kawasumi; T Takashima; H Toba; S Kishimoto
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  The antituberculous Mycobacterium bovis BCG vaccine is an attenuated mycobacterial producer of phosphorylated nonpeptidic antigens for human gamma delta T cells.

Authors:  P Constant; Y Poquet; M A Peyrat; F Davodeau; M Bonneville; J J Fournié
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects.

Authors:  Karina I Carvalho; Solange Maeda; Luciana Marti; Jane Yamashita; Patrick A J Haslett; Esper G Kallas
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.